Adenosine-A1 receptor agonist induced hyperalgesic priming type II

Pain

Volumn 157, Issue 3, 2016, Pages 698-709

  Araldi, Dioneia ^a   Ferrari, Luiz F ^a   Levine, Jon D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

A1 adenosine receptor; Chronic pain; Hyperalgesia; Hyperalgesic priming; i subunit

Indexed keywords

ADENOSINE A1 RECEPTOR AGONIST; ANTISENSE OLIGODEOXYNUCLEOTIDE; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; ISOLECTIN B4; MU OPIATE RECEPTOR AGONIST; PHOSPHOLIPASE C BETA3; PROSTAGLANDIN E2; ADENOSINE; ADENOSINE A1 RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; N(6)-CYCLOPENTYLADENOSINE;

ANIMAL EXPERIMENT; ARTICLE; CHRONIC PAIN; FEMALE; HYPERALGESIA; MALE; NONHUMAN; PAIN RECEPTOR; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; REPEATED DRUG DOSE; TYPE II HYPERALGESIC PRIMING; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICALLY INDUCED; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ADENOSINE; ADENOSINE A1 RECEPTOR AGONISTS; ANIMALS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; FEMALE; HYPERALGESIA; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A1;

EID: 84962114163     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1097/j.pain.0000000000000421     Document Type: Article

References (68)

1. Aley KO, Green PG, Levine JD. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal. J Neurosci 1995;15:8031-8.
2. Aley KO, Levine JD. Dissociation of tolerance and dependence for opioid peripheral antinociception in rats. J Neurosci 1997;17:3907-12.
3. Aley KO, Levine JD. Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal. J Neurosci 1997;17: 735-44.
4. Aley KO, Martin A, McMahon T, Mok J, Levine JD, Messing RO. Nociceptor sensitization by extracellular signal-regulated kinases. J Neurosci 2001;21:6933-9.
5. Aley KO, Messing RO, Mochly-Rosen D, Levine JD. Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C. J Neurosci 2000;20:4680-5.
6. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 2006;104:570-87.
7. Araldi D, Ferrari LF, Levine JD. Repeated Mu-opioid exposure induces a novel form of the hyperalgesic priming model for transition to chronic pain. J Neurosci 2015;35:12502-17.
8. Bogen O, Alessandri-Haber N, Chu C,Gear RW, Levine JD. Generation of a pain memory in the primary afferent nociceptor triggered by PKCepsilon activation of CPEB. J Neurosci 2012;32:2018-26.
9. Bogen O, Bender O, Lowe J, Blenau W, Thevis B, Schroder W, Margolis RU, Levine JD, Hucho F. Neuronally produced versican V2 renders C-fiber nociceptors IB4-positive. J Neurochem 2015;134:147-55.
10. Borle AB, Snowdowne KW. Measurement of intracellular free calcium in monkey kidney cells with aequorin. Science 1982;217:252-4.
11. Burch RM, Axelrod J. Dissociation of bradykinin-induced prostaglandin formation from phosphatidylinositol turnover in Swiss 3T3 fibroblasts: evidence forGprotein regulation of phospholipase A2. Proc Natl Acad Sci U S A 1987;84:6374-8.
12. Chen Y, Yang C, Wang ZJ. Ca21/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesia. J Neurosci 2010;30:38-46.
13. Cheng X, Ma Y, Moore M, Hemmings BA, Taylor SS. Phosphorylation and activation of cAMP-dependent protein kinase by phosphoinositidedependent protein kinase. Proc Natl Acad Sci U S A 1998;95:9849-54.
14. Chiavegatti T, Costa VL Jr, Araujo MS, Godinho RO. Skeletal muscle expresses the extracellular cyclic AMP-adenosine pathway. Br J Pharmacol 2008;153:1331-40.
15. Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain 2008;24: 479-96.
16. Dina OA, Khasar SG, Gear RW, Levine JD. Activation of Gi induces mechanical hyperalgesia poststress or inflammation. Neuroscience 2009;160:501-7.
17. Dowd E, McQueen DS, Chessell IP, Humphrey PP. Adenosine A1 receptor-mediated excitation of nociceptive afferents innervating the normal and arthritic rat knee joint. Br J Pharmacol 1998;125:1267-71.
18. Duarte T, Menezes-Rodrigues FS, Godinho RO. Contribution of the extracellular cAMP-adenosine pathway to dual coupling of beta2-adrenoceptors to Gs and Gi proteins in mouse skeletal muscle. J Pharmacol Exp Ther 2012;341:820-8.
19. Ferrari LF, Bogen O, Alessandri-Haber N, Levine E, Gear RW, Levine JD. Transient decrease in nociceptor GRK2 expression produces long-term enhancement in inflammatory pain. Neuroscience 2012;222:392-403.
20. Ferrari LF, Bogen O, Chu C, Levine JD. Peripheral administration of translation inhibitors reverses increased hyperalgesia in a model of chronic pain in the rat. J Pain 2013;14:731-8.
21. Ferrari LF, Bogen O, Levine JD. Nociceptor subpopulations involved in hyperalgesic priming. Neuroscience 2010;165:896-901.
22. Ferrari LF, Bogen O, Levine JD. Role of nociceptor alphaCaMKII in transition from acute to chronic pain (hyperalgesic priming) in male and female rats. J Neurosci 2013;33:11002-11.
23. Ferrari LF, Bogen O, Levine JD. Second messengers mediating the expression of neuroplasticity in a model of chronic pain in the rat. J Pain 2014;15:312-20.
24. Ferrari LF, Bogen O, Reichling DB, Levine JD. Accounting for the delay in the transition from acute to chronic pain: axonal and nuclear mechanisms. J Neurosci 2015;35:495-507.
25. Ferrari LF, Levine E, Levine JD. Role of a novel nociceptor autocrine mechanism in chronic pain. Eur J Neurosci 2013;37:1705-13.
26. Ferrari LF, Levine JD. Plasma membrane mechanisms in a preclinical rat model of chronic pain. J Pain 2015;16:60-6.
27. Hurt JK, Zylka MJ. PAPupuncture has localized and long-lasting antinociceptive effects in mouse models of acute and chronic pain. Mol Pain 2012;8:28.
28. Johnson JA, Gray MO, Chen CH, Mochly-Rosen D. A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J Biol Chem 1996;271:24962-6.
29. Joseph EK, Bogen O, Alessandri-Haber N, Levine JD. PLC-beta 3 signals upstream of PKC epsilon in acute and chronic inflammatory hyperalgesia. PAIN 2007;132:67-73.
30. Joseph EK, Chen X, Bogen O, Levine JD. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. J Pain 2008;9:463-72.
31. Joseph EK, Levine JD. Hyperalgesic priming is restricted to isolectin B4-positive nociceptors. Neuroscience 2010;169:431-5.
32. Joseph EK, Levine JD. Multiple PKCepsilon-dependent mechanisms mediating mechanical hyperalgesia. PAIN 2010;150:17-21.
33. Joseph EK, Parada CA, Levine JD. Hyperalgesic priming in the rat demonstrates marked sexual dimorphism. PAIN 2003;105:143-50.
34. Joseph EK, Reichling DB, Levine JD. Shared mechanisms for opioid tolerance and a transition to chronic pain. J Neurosci 2010;30: 4660-6.
35. Khasar SG, Burkham J, Dina OA, Brown AS, Bogen O, Alessandri-Haber N, Green PG, Reichling DB, Levine JD. Stress induces a switch of intracellular signaling in sensory neurons in a model of generalized pain. J Neurosci 2008;28:5721-30.
36. Khasar SG, Lin YH, Martin A, Dadgar J, McMahon T, Wang D, Hundle B, Aley KO, Isenberg W, McCarter G, Green PG, Hodge CW, Levine JD, Messing RO. A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice. Neuron 1999;24:253-60.
37. Khasar SG, Wang JF, Taiwo YO, Heller PH, Green PG, Levine JD. Muopioid agonist enhancement of prostaglandin-induced hyperalgesia in the rat: a G-protein beta gamma subunit-mediated effect? Neuroscience 1995;67:189-95.
38. Konopka KH, van Wijhe M. Opioid-induced hyperalgesia: pain hurts? Br J Anaesth 2010;105:555-7.
39. Korboukh I, Hull-Ryde EA, Rittiner JE, Randhawa AS, Coleman J, Fitzpatrick BJ, Setola V, Janzen WP, Frye SV, Zylka MJ, Jin J. Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice. J Med Chem 2012;55:6467-77.
40. Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician 2011;14:145-61.
41. Levine JD, Taiwo YO. Involvement of the mu-opiate receptor in peripheral analgesia. Neuroscience 1989;32:571-5.
42. Mantyh PW, Hunt SP. Hot peppers and pain. Neuron 1998;21:644-5.
43. Mao J. Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. PAIN 2002;100:213-17.
44. Mestre C, Pelissier T, Fialip J, Wilcox G, Eschalier A. Amethod to perform direct transcutaneous intrathecal injection in rats. J Pharmacol Toxicol Methods 1994;32:197-200.
45. Nishiguchi J, Sasaki K, Seki S, Chancellor MB, Erickson KA, de Groat WC, Kumon H, Yoshimura N. Effects of isolectin B4-conjugated saporin, a targeting cytotoxin, on bladder overactivity induced by bladder irritation. Eur J Neurosci 2004;20:474-82.
46. Ossipov MH, Lai J, King T, Vanderah TW, Porreca F. Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure. Biopolymers 2005;80:319-24.
47. Parada CA, Reichling DB, Levine JD. Chronic hyperalgesic priming in the rat involves a novel interaction between cAMP and PKCepsilon second messenger pathways. PAIN 2005;113:185-90.
48. Parada CA, Yeh JJ, Joseph EK, Levine JD. Tumor necrosis factor receptor type-1 in sensory neurons contributes to induction of chronic enhancement of inflammatory hyperalgesia in rat. Eur J Neurosci 2003; 17:1847-52.
49. Parada CA, Yeh JJ, Reichling DB, Levine JD. Transient attenuation of protein kinase Cepsilon can terminate a chronic hyperalgesic state in the rat. Neuroscience 2003;120:219-26.
50. Pierre S, Eschenhagen T, Geisslinger G, Scholich K. Capturing adenylyl cyclases as potential drug targets. Nat Rev Drug Discov 2009;8:321-35.
51. Quanhong Z, Ying X, Moxi C, Tao X, JingW, Xin Z, Li W, Derong C, Xiaoli Z, Wei J. Intrathecal PLC(beta3) oligodeoxynucleotides antisense potentiates acute morphine efficacy and attenuates chronic morphine tolerance. Brain Res 2012;1472:38-44.
52. Reichling DB, Levine JD. Critical role of nociceptor plasticity in chronic pain. Trends Neurosci 2009;32:611-18.
53. Rittiner JE, Korboukh I, Hull-Ryde EA, Jin J, Janzen WP, Frye SV, Zylka MJ. AMP is an adenosine A1 receptor agonist. J Biol Chem 2012;287: 5301-9.
54. Snider WD, McMahon SB. Tackling pain at the source: new ideas about nociceptors. Neuron 1998;20:629-32.
55. Song MJ, Wang YQ, Wu GC. Additive anti-hyperalgesia of electroacupuncture and intrathecal antisense oligodeoxynucleotide to interleukin-1 receptor type I on carrageenan-induced inflammatory pain in rats. Brain Res Bull 2009;78:335-41.
56. Sowa NA, Taylor-Blake B, Zylka MJ. Ecto-5'-nucleotidase (CD73) inhibits nociception by hydrolyzing AMP to adenosine in nociceptive circuits. J Neurosci 2010;30:2235-44.
57. Street SE, Walsh PL, Sowa NA, Taylor-Blake B, Guillot TS, Vihko P, Wightman RM, Zylka MJ. PAP and NT5E inhibit nociceptive neurotransmission by rapidly hydrolyzing nucleotides to adenosine. Mol Pain 2011;7:80.
58. Stucky CL, Lewin GR. Isolectin B(4)-positive and-negative nociceptors are functionally distinct. J Neurosci 1999;19:6497-505.
59. Su L, Wang C, Yu YH, Ren YY, Xie KL, Wang GL. Role of TRPM8 in dorsal root ganglion in nerve injury-induced chronic pain. BMC Neurosci 2011; 12:120.
60. Sun JL, Xiao C, Lu B, Zhang J, Yuan XZ, Chen W, Yu LN, Zhang FJ, Chen G, Yan M. CX3CL1/CX3CR1 regulates nerve injury-induced pain hypersensitivity through the ERK5 signaling pathway. J Neurosci Res 2013;91:545-53.
61. Taiwo YO, Bjerknes LK, Goetzl EJ, Levine JD. Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system. Neuroscience 1989;32:577-80.
62. Taiwo YO, Levine JD. Prostaglandin effects after elimination of indirect hyperalgesic mechanisms in the skin of the rat. Brain Res 1989;492: 397-9.
63. Taiwo YO, Levine JD. Direct cutaneous hyperalgesia induced by adenosine. Neuroscience 1990;38:757-62.
64. Taiwo YO, Levine JD. Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience 1991;44:131-5.
65. van Calker D, Muller M, Hamprecht B. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem 1979;33:999-1005.
66. Vulchanova L, Olson TH, Stone LS, Riedl MS, Elde R, Honda CN. Cytotoxic targeting of isolectin IB4-binding sensory neurons. Neuroscience 2001;108:143-55.
67. Zahn PK, Straub H, Wenk M, Pogatzki-Zahn EM. Adenosine A1 but not A2a receptor agonist reduces hyperalgesia caused by a surgical incision in rats: a pertussis toxin-sensitive G protein-dependent process. Anesthesiology 2007;107:797-806.
68. Zylka MJ. Pain-relieving prospects for adenosine receptors and ectonucleotidases. Trends Mol Med 2011;17:188-96.